scholarly journals Recurrent hypertrophic pulmonary osteoarthropathy in an adult with bronchiectasis

2020 ◽  
Vol 8 (6) ◽  
Author(s):  
Amelia Tekiteki ◽  
William R. Good ◽  
Benjamin Diggins ◽  
Graeme Anderson ◽  
Conroy A. Wong

2010 ◽  
Vol 17 (3) ◽  
pp. 113-114 ◽  
Author(s):  
George Rakovich ◽  
Maxime Laflamme ◽  
Denise Ouellette ◽  
Gilles Beauchamp

Solitary fibrous tumours of the pleura are rare pleural neoplasms that are distinct from mesothelioma. Most of them are benign, although some behave aggressively; morphological and pathological features are important in distinguishing them from mesothelioma and in predicting clinical behaviour. Solitary fibrous tumours often grow to a large size before causing symptoms, and are characteristically associated with hypertrophic pulmonary osteoarthropathy in up to 20% of cases. In cases of benign lesions, complete resection is usually curative. A case involving a 62-year-old woman who underwent surgical resection of a solitary fibrous tumour of the pleura measuring 25 cm in size is described.



BMJ ◽  
1977 ◽  
Vol 2 (6095) ◽  
pp. 1151-1152 ◽  
Author(s):  
T C Stokes ◽  
P J Ell ◽  
J Deacon


2020 ◽  
pp. 4598-4612
Author(s):  
Stuart Carter ◽  
Lisa Dunkley ◽  
Ade Adebajo

Musculoskeletal symptoms can occur in a variety of diseases, or as drug side effects. Presentations and conditions discussed in this section include: multisystem diseases (e.g. adult-onset Still’s disease, acute sarcoid arthritis, and amyloidosis); paraneoplastic syndromes (e.g. hypertrophic pulmonary osteoarthropathy, remitting seronegative symmetrical synovitis with pitting oedema, and tumour-induced osteomalacia); skin manifestations of rheumatic disease (e.g. panniculitis, neutrophilic dermatoses, and multicentric reticulohistiocytosis); primary joint pathology and synovial disorders (e.g. pigmented vilonodular synovitis, synovial osteochondromatosis, Charcot joint); rheumatic manifestations of haematological disease (e.g. haemophilia, sickle cell disease, leukaemia, lymphoma, and polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin abnormalities); rheumatic manifestations of metabolic disease (e.g. hereditary haemochromatosis, Wilson’s disease); disorders of the spine and axial skeleton (e.g. Tietze’s syndrome, diffuse idiopathic skeletal hyperostosis, and alkaptonuria); drug-induced rheumatic syndromes (e.g. statin-induced myopathy, drug-induced tendinopathy, drug-induced lupus, and allopurinol hypersensitivity).



2012 ◽  
Vol 1 (3) ◽  
pp. 161
Author(s):  
Kaushik Saha ◽  
Arnab Maji ◽  
Debraj Jash ◽  
NiranjanKumar Sit






2011 ◽  
Vol 29 (4) ◽  
pp. 302-307 ◽  
Author(s):  
Malathy Kilaru ◽  
Caroline Vitale ◽  
Marcos Montagnini


Sign in / Sign up

Export Citation Format

Share Document